Office of Technology Transfer & Business Development
Technologies Available for Licensing
Diagnostics    |    Therapeutics    |    Devices    |    Drug Discovery    |    Other

Therapeutics

Case Number Title Non-Confidential Summary Issued Patent Lead Inventor's Website
BAR_GIA.007 A new way of stimulating the nerves fibers in the lumbar area to relieve severe intractable low back pain            
BER_ERI.001 Use of Tempol in the Prevention of Photoaging   [US Patent No. 5,840,734]
     
Link
BER_WOL.001 CalDAG-GEFI Inhibitors as Anti-Platelet Drugs NCS for BER_WOL.001          
BLO_TIM.002 Glucosidase Inhibitors as a Treatment for Viruses that Bud from the Endoplasmic Reticulum            
CON_PAU.001 Use Of Magnetic Particles In The Focal Delivery Of Cells   [US Patent No. 6,203,487]
     
 
CRO_CAR.002 Compositions, Kits and Methods Relating to the Human FEZ1 Gene, a Novel Tumor Suppressor Gene NCS for Croce tumor suppressor techs (CRO 2,4,5,16)          
CRO_CAR.004 The Human FHIT Gene NCS for Croce tumor suppressor techs (CRO 2,4,5,16) [United States Patent: 7220834]
[United States Patent: 6774217]
[United States Patent: 6242212]
[United States Patent: 5928884]
 
CRO_CAR.009 TCL-1 Gene And Protein And Related Methods And Compositions NCS for Croce TCL-1 techs (CRO 9,15)          
CRO_CAR.015 Human Chronic Lymphocytic Leukemia Modeled in Mouse by Targeted TCL1 Expression NCS for Croce TCL-1 techs (CRO 9,15)          
CRO_CAR.016 Novel Tumor Suppressor Gene and Compositions and Methods for Making and Using the Same NCS for Croce tumor suppressor techs (CRO 2,4,5,16)          
CRO_CAR.017 Role of microRNA Genes In Human Cancer NCS for Croce miRNA techs (CRO 17, 25)          
CRO_CAR.019 Involvement Of The ALL-1 Gene In A Solid Tumor1   [US Patent No. 5,567,586]
     
 
CRO_CAR.025 microRNA genes in cancer diagnosis and treatment NCS for Croce miRNA techs (CRO 17, 25)          
DAN_REN.001 Inhibition of HIV-1 replication in human peripheral blood monocytes through a clinically used drug           Link
DES_SCO.007 Human Antibodies that Bind Amyloid Proteins            
DIE_BER.010 Recombinant Rabies for Pre- and Post-Exposure Prophylaxis           Link
FOR_FLE.002 Selection of Subharmonic Pressure Estimates NCS for FOR_FLE.002         Link
HOL_MIC.001 Inhibitors of Human 12-Lipoxygenase            
HOU_YAM.005 Apoptosis of Cardiomyocytes           Link
HOU_YAM.006 Antibiotics Targeting a Growth-Dependent Bacterial Enzyme           Link
IOZ_REN.001 A Role For Decorin In Tumor Suppression   [US Patent No. 6,524,573]
     
Link
IWA_MAS.003 Pharmacologic Treatment for Muscle Repair NCS for IWA_MAS.003         Link
KAS_DAV.001 A Small Bowel Purgative for Wireless Capsule Endoscopy NCS for KAS_DAV.001          
KMI_ERI.005 Methods for Enhancing Gene Conversion or Genetic Repair by Chimeric Oligonucleotides            
KOC_WAL.005 Adrenal Beta-Arrestin 1 is a Critical Regulator of Post-Myocardial Infarction Aldosterone Levels During Progression to Heart Failure           Link
KOP_HIL.006 Polypeptides Fused with Alfalfa Mosaic Virus or Ilarvirus Capsid Proteins   [US Patent No. 6,042,832]
[US Patent No. 6,448,070]
   
Link
KWO_SIM.001 Novel Tumor Suppressor Encoding Nucleic Acid, PTX1, and Methods of Use Thereof NCS for KWO_SIM.001 [US Patent No. 6,743,603]
     
 
MCM_STE.002 Novel Mechanism for Control of AR Function in Prostate Cancer            
MEN_SUE.004 Method for Treatment of PCO           Link
OST_JEW.002 Intra-Peritoneal Perfusion of Oxygenated Fluorocarbons   [US Patent No. 4,657,532]
[US Patent No. 4,963,130]
   
Link
PEZ_TIF.001H Secretion Free Continuous Nebulizer NCS for PEZ_TIF.001H          
POD_TAR.005 Robotic Biopsy and Lumpectomy            
PRI_EDM.005 A Pocketsized Medical Auto-Injector NCS for PRI_EDM.005         Link
RAB_JOS.001 Development of an Enhancer/Promoter Pair for Heart Selective Gene Expression NCS for RAB_JOS.001         Link
SAN_JAM.001 Peptides with High Affinity for Heparin and for Proteoglycans to be used to Promote Endothelialization of Synthetic Vascular Graft Surfaces, or to Target the Delivery of Drugs to Cell Surfaces NCS for SAN_JAM.001, .002 [US Patent No. 6,855,801]
     
Link
SAN_JAM.002 Peptides that Neutralize Heparin or Proteoglycans, or Promote Cell Adhesion or Drug Delivery NCS for SAN_JAM.001, .002 [US Patent No. 7,259,140]
     
Link
SCH_JAY.001 Treatment of Parkinson's Disease with Oligonucleotide and Triplex Technology NCS for SCH_JAY.001, 002, 004, 008         Link
SCH_JAY.002 Partial Agonists at the Glycine Modulatory Site of the NMDA Receptor for Treating Cognitive Dysfunction in Parkinson's Disease NCS for SCH_JAY.001, 002, 004, 008         Link
SCH_JAY.004 Method of Treating Parkinson's Disease and Composition for the Same NCS for SCH_JAY.001, 002, 004, 008 [United States Patent: 7160913]
     
Link
SCH_JAY.008 Treatment of Parkinson's Disease and Parkinson's Disease Treatment-related Complications with RNA Inhibition Therapies NCS for SCH_JAY.001, 002, 004, 008         Link
SCH_MAT.010 Polypeptides Inducing Neuron Survival, Polynucleotides Encoding Them and Therapeutic Uses Thereof           Link
SHI_YI.008 Prevention and Treatment of Metabolic Disorder-Associated Osteopenia/Osteoporosis and Bone Marrow Abnormalities            
SHI_YI.010 Prevention and Treatment of Vascular Dementia and Alzheimer's Disease            
STR_DAV.001 SV40 Viral Vectors for Targeted Integration Into Cells   [US Patent No. 5,863,794]
     
Link
SUN_XIA.001 Implantable Sensor and System for Measurement and Control of Blood Constituent Levels   [US Patent No. 5,995,860]
[US Patent No. 6,122,536]
   
 
SYK_YUR.004 Invention of a Novel Serum Free Media for Cultivation of Hybridoma Cells to Achieve Production of Highly Homogenous Monoclonal Antibodies (MAb) in Preparative Scale NCS for SYK_YUR.004         Link
THA_MAT.002 Lipid soluble radioactive metal chelates for tumor therapy NCS for THA_MAT.002 [US Patent No. 6,685,913]
     
Link
THO_JEF.001 Nitric Oxide Donor Compositions, Methods, Apparatus, and Kits for Alleviating Vasoconstriction and Vasospasm in a Mammal   [US Patent No. 6,358,536]
     
 
WIL_JOH.005 Design and Development of Masked Therapeutic Antibodies to Limit Off-Target Effects: Application to Anti-EGFR Antibodies (Also known as "EGFR-Specific ScFvs Engineered to Enable Selective Antigen Recognition Upon Proteolytic Activation")            
ZAL_AND.002 Inhibition of Extracellular Matrix Synthesis By Antisense Compounds Directed to Nuclear Proto-Oncogenes   [US Patent No. 6,133,242]
     
 

Click to leave feedback
feedback